Total Xenoestrogen Body Burden in Relation to Mammographic Density, a Marker of Breast Cancer Rlisk

Completed

Conditions studied: Breast Cancer Risk

In brief

Mammographic density is sensitive to estorgen exposure and constitutes a strong intermediate maker of breast cancer risk. We hypothesize that women with higher serum xenoestrogen levels will have greater mammographic density.

Key facts

Study ID

NCT00839696

Run by

University of Wisconsin, Madison

People needed

270

Starts

2008-07-01

Expected to finish

2010-04-01

Last updated by the study team

2019-11-19

Who can join

Age: 55 and older, up to 70. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• 55-70 years of age, Post menopausal

You may not qualify if…

• If they have ever used hormone replacment therapy or have ever used Tamoxifen or Raloxifene, Diag. with breast cancer have had breast implants or have had a mastectomy/

Where it is running

• University of Wisconsin Hospital — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.